Breaking News Instant updates and real-time market news.

YMAB

Y-mAbs Therapeutics

$28.51

-0.03 (-0.11%)

16:26
11/19/19
11/19
16:26
11/19/19
16:26

Y-mAbs Therapeutics initiated with a Buy at Guggenheim

Guggenheim analyst Etzer Darout initiated coverage of Y-mAbs Therapeutics with a Buy rating and $40 price target.

YMAB Y-mAbs Therapeutics
$28.51

-0.03 (-0.11%)

04/01/19
HCWC
04/01/19
INITIATION
Target $36
HCWC
Buy
Y-mAbs Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Y-mAbs Therapeutics with a Buy rating and $36 price target. The company has a "highly differentiated business model," focusing on rare, hitherto difficult-to-treat pediatric cancers with next-generation monoclonal antibody therapeutics, Selvaraju tells investors in a research note. He believes the company's is a platform "possesses multiple advantages."
06/10/19
HCWC
06/10/19
NO CHANGE
Target $40
HCWC
Buy
Y-mAbs Therapeutics price target raised to $40 from $36 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Y-mAbs Therapeutics to $40 from $36 saying he's encouraged by omburtamab's efficacy in diffuse intrinsic pontine glioma. Further, he believes the drug's efficacy results may improve in later-stage trials. The analyst reiterates a Buy rating on Y-mAbs.
09/03/19
WEDB
09/03/19
INITIATION
Target $38
WEDB
Outperform
Y-mAbs Therapeutics initiated with an Outperform at Wedbush
Wedbush analyst David Nierengarten started Y-mAbs Therapeutics with an Outperform rating and $38 price target.
09/04/19
09/04/19
INITIATION
Target $38

Outperform
Wedbush bullish on Y-mAbs Therapeutics, initiates with an Outperform
As previously reported, Wedbush analyst David Nierengarten started coverage of Y-mAbs Therapeutics with an Outperform rating and $38 price target. The analyst views the shares as "undervalued" based on the company's core, late stage assets' market opportunities supporting the current share price, with investors enjoying a low/no-cost option to label expansions and earlier-stage pipeline efforts. In particular, with potentially heightened market volatility due to macroeconomic and political factors over the next 12 months, Nierengarten feels that companies with Y-mAbs' profile should be particularly attractive for investors.

TODAY'S FREE FLY STORIES

12:30
12/06/19
12/06
12:30
12/06/19
12:30
General news
Treasury's $25 B 2-year FRN reopening stopped at 0.245% »

Treasury's $25 B…

PIR

Pier 1 Imports

$7.70

-0.27 (-3.39%)

12:22
12/06/19
12/06
12:22
12/06/19
12:22
Periodicals
Pier 1 hired Guggenheim amid concerns over debt, Debtwire reports »

Pier 1 Imports has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLA

Medallia

$29.11

-0.68 (-2.28%)

12:19
12/06/19
12/06
12:19
12/06/19
12:19
Recommendations
Medallia analyst commentary  »

Oppenheimer says would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

PIR

Pier 1 Imports

$7.92

-0.05 (-0.63%)

12:19
12/06/19
12/06
12:19
12/06/19
12:19
Periodicals
Breaking Periodicals news story on Pier 1 Imports »

Pier 1 hired financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/06/19
12/06
12:17
12/06/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/06/19
12/06
12:16
12/06/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$60.70

1.195 (2.01%)

, XLRN

Acceleron

$48.58

-0.08 (-0.16%)

12:08
12/06/19
12/06
12:08
12/06/19
12:08
Hot Stocks
Bristol-Myers, Acceleron: FDA says Reblozyl will not be reviewed at ODAC meeting »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$60.70

1.195 (2.01%)

XLRN

Acceleron

$48.58

-0.08 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

  • 11

    Dec

  • 04

    Apr

MNTA

Momenta

$17.53

0.68 (4.04%)

12:04
12/06/19
12/06
12:04
12/06/19
12:04
Hot Stocks
Momenta granted orphan status for hemolytic anemia treatment »

The FDA granted Momenta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

EA

Electronic Arts

$102.74

0.66 (0.65%)

, ATVI

Activision Blizzard

$55.08

0.09 (0.16%)

12:03
12/06/19
12/06
12:03
12/06/19
12:03
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

EA

Electronic Arts

$102.74

0.66 (0.65%)

ATVI

Activision Blizzard

$55.08

0.09 (0.16%)

GME

GameStop

$6.46

0.1 (1.57%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$123.21

-0.69 (-0.56%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 13

    Dec

PRVL

Prevail Therapeutics

$14.02

-0.03 (-0.21%)

12:02
12/06/19
12/06
12:02
12/06/19
12:02
Hot Stocks
Prevail Therapeutics granted orphan status for dementia treatment »

The FDA granted Prevail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEI

Weidai

$4.10

-0.35 (-7.87%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Weidai falls -8.3% »

Weidai is down -8.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PD

PagerDuty

$21.79

-3.2 (-12.81%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
PagerDuty falls -12.8% »

PagerDuty is down -12.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$14.02

-2.595 (-15.62%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Yext falls -15.4% »

Yext is down -15.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$17.08

2.02 (13.41%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Chemours rises 13.4% »

Chemours is up 13.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

BIG

Big Lots

$24.21

5.04 (26.29%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Big Lots rises 26.5% »

Big Lots is up 26.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

GCO

Genesco

$49.57

12.63 (34.19%)

12:00
12/06/19
12/06
12:00
12/06/19
12:00
Hot Stocks
Genesco rises 34.1% »

Genesco is up 34.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

UBER

Uber

$27.99

-0.655 (-2.29%)

, ALXN

Alexion

$112.31

4.89 (4.55%)

11:58
12/06/19
12/06
11:58
12/06/19
11:58
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been…

UBER

Uber

$27.99

-0.655 (-2.29%)

ALXN

Alexion

$112.31

4.89 (4.55%)

TTD

Trade Desk

$250.86

10.59 (4.41%)

BIG

Big Lots

$24.19

5.02 (26.19%)

ULTA

Ulta Beauty

$267.17

31.08 (13.16%)

CIEN

Ciena

$34.98

-1.32 (-3.64%)

PD

PagerDuty

$21.81

-3.18 (-12.73%)

YEXT

Yext

$13.99

-2.625 (-15.80%)

ZM

Zoom Video

$62.23

-7.5 (-10.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 16

    Dec

  • 16

    Dec

  • 12

    Mar

11:58
12/06/19
12/06
11:58
12/06/19
11:58
Conference/Events
Oppenheimer healthcare analysts to hold a KOL dinner meeting »

Analysts hold a Cardiac…

F

Ford

$9.06

0.13 (1.46%)

11:58
12/06/19
12/06
11:58
12/06/19
11:58
Hot Stocks
Ford issues two safety recalls in North America »

Ford Motor Company is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 07

    Jan

  • 04

    Feb

11:57
12/06/19
12/06
11:57
12/06/19
11:57
Conference/Events
William Blair insurance analyst to hold a luncheon meeting »

Insurance Analyst Adam…

11:55
12/06/19
12/06
11:55
12/06/19
11:55
Conference/Events
BTIG oil and tanker analysts to hold a roundtable »

Oil Flow & Tanker…

GS

Goldman Sachs

$223.33

6.1 (2.81%)

11:54
12/06/19
12/06
11:54
12/06/19
11:54
Periodicals
U.S. discussing Goldman Sachs settlement for 1MDB under $2B, Bloomberg says »

The DOJ and other federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

  • 26

    Feb

GGG

Graco

$49.25

0.84 (1.74%)

11:53
12/06/19
12/06
11:53
12/06/19
11:53
Hot Stocks
Graco raises quarterly dividend 9.4% to 17.5c per share »

Graco's board has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZGNX

Zogenix

$46.15

0.5 (1.10%)

11:44
12/06/19
12/06
11:44
12/06/19
11:44
Recommendations
Zogenix analyst commentary  »

2020 looking to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

ARD

Ardagh Group

$18.88

(0.00%)

, CCK

Crown Holdings

$76.07

0.26 (0.34%)

11:42
12/06/19
12/06
11:42
12/06/19
11:42
Recommendations
Ardagh Group, Crown Holdings, Ball Corp. analyst commentary  »

FCD can plant news…

ARD

Ardagh Group

$18.88

(0.00%)

CCK

Crown Holdings

$76.07

0.26 (0.34%)

BLL

Ball Corp.

$66.18

0.02 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.